Free Pediatrics CME 2017‑2018 | CMEList.com

 


Lennox-Gastaut Syndrome: Improving Patient Outcomes Through Better Diagnosis and Management Free Neurology CME 
Live online October 7, 2016, and available on demand through October 13, 2017.
Posted by...Bernard Sklar, MD.
Free Neurology CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine and Montefiore Medical Center.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for US-based epileptologists, community neurologists (pediatric and adult), primary care physicians, pediatricians, medical directors from long-term care facilities, and other clinicians involved in the care of patients with Lennox-Gastaut Syndrome.
Educational material updated... October 7, 2016.
Expiration of CME credit... October 13, 2017.
Financial Support...Lundbeck.
Topics covered in Lennox-Gastaut Syndrome include: 
• Barriers to effective diagnosis and management of LGS (Lennox-Gastaut Syndrome) in pediatric and adult settings
• What is the "triad" and evolving seizure patterns of LGS as patients age
• Diagnostic approaches to differentiate LGS from other forms of epileptic encephalopathies
• Management strategies as patients age, seizure characteristics change, and behavioral or other issues arise
• Multidisciplinary approach to lifelong management of LGS and key elements for a smooth transition from pediatric to adult services
At the conclusion of Lennox-Gastaut Syndrome, you will be better able to:
• Identify characteristics associated with LGS from other forms of epilepsy, and evolving seizure profiles over the course of a patient's life
• Devise effective and tolerable pharmacotherapeutic treatment options for LGS as appropriate to pediatric and adult patients
• Evaluate the relative efficacy and safety of alternative therapies and nonpharmacologic strategies for the management of LGS
• Describe the key elements of a care plan that will ensure smooth transition from pediatric care to adult care in patients with LGS

Pediatric Patients with High-Risk Neuroblastoma: Perspectives on Diagnosis and Management Free Cancer CME
Live online June 9, 2016, and available on demand through September 20, 2017.
Posted by...Bernard Sklar, MD.
Free Cancer CME Credit hours...1.0.
CME Credits Awarded by....Postgraduate Institute for Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for oncologists, surgeons, nurses, pharmacists, physician assistants, and health care providers who care for or have an interest in pediatric patients with high-risk neuroblastoma.
Educational material updated...June 9, 2016.
Expiration of CME credit...September 20, 2017.
Financial Support...United Therapeutics.
Topics covered by Pediatric Patients with High-Risk Neuroblastoma include:
• Treatment options for the management of high-risk pediatric neuroblastoma, including chemotherapy, surgery, radiotherapy, and immunological treatments 
• Managing immediate and late effects of therapy for pediatric neuroblastoma 
• Patient-related needs associated with agents used for high-risk pediatric neuroblastoma 
• Current evidence-based practice and research topics regarding the care of pediatric patients with high-risk neuroblastoma
• Collaborative comprehensive care for patients with high-risk pediatric neuroblastoma
• Current evidence-based practice and research topics regarding the care of pediatric patients with high-risk neuroblastoma 
At the conclusion of Pediatric Patients with High-Risk Neuroblastoma, you will be able to:
• Review treatment options for the management of high-risk pediatric neuroblastoma, including chemotherapy, surgery, radiotherapy, and immunological treatments
• Manage immediate and late effects of therapy for pediatric neuroblastoma
• Describe patient-related needs associated with agents used for high-risk pediatric neuroblastoma
• Evaluate current evidence-based practice and research topics regarding the care of pediatric patients with high-risk neuroblastoma
• Provide collaborative comprehensive care for patients with high-risk pediatric neuroblastoma